Literature DB >> 1185611

The effect of curare on the release of acetylcholine from mammalian motor nerve terminals and an estimate of quantum content.

P Fletcher, T Forrester.   

Abstract

Curarized and non-curarized rat hemidiaphragm muscles were indirectly stimulated in vitro. 2. The fluid bathing the active curarized muscles was eluted through a dextran gel (Sephadex G-10), effecting a complete separation of ACh from curare. The acetylcholine fraction was then assayed on an isometric leech muscle preparation. 3. Prostaglandin (PGE1) in a concentration fifteen times that estimated to be released from the skeletal muscle preparation did not affect the response of leech muscle to ACh. 4. The amount of ACh released by curarized muscles (4-9 X 10(-18) mole/impulse-junction) was not significantly different from that released by non-curarized muscles (4-6 X 10(-18) mole/impulse-junction). These quantities are similar to those obtained by previous workers. It is concluded that curare in a paralytic dose does not affect the output of ACh from motor nerve terminals stimulated at low frequencies. 5. Spontaneous release of ACh from non-curarized muscles was estimated at 0-45-0-65 p-mole/min. hemidiaphragm. It is calculated that only 2% of this amount could give rise to post-synaptic electrical events, the remainder having a non-synaptic source. 6. The number of molecules of 'quantal' ACh released by stimulated muscle is calculated as 2-5 X 10(6)/impulse-junction, taking account of the non-synaptic release. The number of ACh molecules in one quantum was estimated to be 6250, an amount that could be easily accommodated in one synaptic vesicle.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1185611      PMCID: PMC1348379          DOI: 10.1113/jphysiol.1975.sp011084

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  31 in total

1.  Presynaptic failure of neuromuscular propagation in rats.

Authors:  K KRNJEVIC; R MILEDI
Journal:  J Physiol       Date:  1959-12       Impact factor: 5.182

2.  An investigation of spontaneous activity at the neuromuscular junction of the rat.

Authors:  A W LILEY
Journal:  J Physiol       Date:  1956-06-28       Impact factor: 5.182

3.  Release of acetylcholine at voluntary motor nerve endings.

Authors:  H H Dale; W Feldberg; M Vogt
Journal:  J Physiol       Date:  1936-05-04       Impact factor: 5.182

4.  The spontaneous release of acetylcholine from the denervated hemidiaphragm of the rat.

Authors:  J F Mitchell; A Silver
Journal:  J Physiol       Date:  1963-01       Impact factor: 5.182

5.  Prejunctional effect of curare: its relative importance.

Authors:  A Galindo
Journal:  J Neurophysiol       Date:  1971-03       Impact factor: 2.714

Review 6.  The prostaglandins: a family of biologically active lipids.

Authors:  S Bergström; L A Carlson; J R Weeks
Journal:  Pharmacol Rev       Date:  1968-03       Impact factor: 25.468

7.  [Influence of d-tubocurarin on the release of acetylcholine by motor nerve-endings].

Authors:  H Bauer
Journal:  Pflugers Arch       Date:  1971       Impact factor: 3.657

8.  The effect of facilitatory concentrations of decamethonium on the storage and release of transmitter at the neuromuscular junction of the cat.

Authors:  L C Blaer
Journal:  J Pharmacol Exp Ther       Date:  1970-12       Impact factor: 4.030

9.  The release of prostaglandin E1 from the rat phrenic nerve-diaphragm preparation.

Authors:  J L Laity
Journal:  Br J Pharmacol       Date:  1969-11       Impact factor: 8.739

10.  Prostaglandin: release from the rat phrenic nerve--diaphragm preparation.

Authors:  P W Ramwell; J E Shaw; J Kucharski
Journal:  Science       Date:  1965-09-17       Impact factor: 47.728

View more
  26 in total

1.  The effects of muscarine and atropine reveal that inhibitory autoreceptors are present on frog motor nerve terminals but are not activated during transmission.

Authors:  M S Arenson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-02       Impact factor: 3.000

2.  iPSC-derived functional human neuromuscular junctions model the pathophysiology of neuromuscular diseases.

Authors:  Chuang-Yu Lin; Michiko Yoshida; Li-Tzu Li; Akihiro Ikenaka; Shiori Oshima; Kazuhiro Nakagawa; Hidetoshi Sakurai; Eriko Matsui; Tatsutoshi Nakahata; Megumu K Saito
Journal:  JCI Insight       Date:  2019-09-19

3.  Studies on neurotrophic regulation of murine skeletal muscle.

Authors:  D A Mathers; S Thesleff
Journal:  J Physiol       Date:  1978-09       Impact factor: 5.182

4.  A study on early post-denervation changes of non-quantal and quantal acetylcholine release in the rat diaphragm.

Authors:  H Zemková; F Vyskocil; C Edwards
Journal:  Pflugers Arch       Date:  1987-08       Impact factor: 3.657

5.  The synthesis of acetylcholine in skeletal muscles of the rat.

Authors:  S Tucek
Journal:  J Physiol       Date:  1982-01       Impact factor: 5.182

6.  Prejunctional modulation of acetylcholine release from the skeletal neuromuscular junction: link between positive (nicotinic)- and negative (muscarinic)-feedback modulation.

Authors:  E S Vizi; G T Somogyi
Journal:  Br J Pharmacol       Date:  1989-05       Impact factor: 8.739

7.  Sources of adenosine released during neuromuscular transmission in the rat.

Authors:  D O Smith
Journal:  J Physiol       Date:  1991-01       Impact factor: 5.182

8.  Decrease of the spontaneous non-quantal release of acetylcholine from the phrenic nerve in botulinum-poisoned rat diaphragm.

Authors:  V Dolezal; F Vyskocil; S Tucek
Journal:  Pflugers Arch       Date:  1983-06-01       Impact factor: 3.657

9.  Release of [3H]acetylcholine from a modified rat phrenic nerve-hemidiaphragm preparation.

Authors:  I Wessler; H Kilbinger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-12       Impact factor: 3.000

10.  Presynaptic nicotine receptors mediating a positive feed-back on transmitter release from the rat phrenic nerve.

Authors:  I Wessler; M Halank; J Rasbach; H Kilbinger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-12       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.